Abstract
Caloric restriction (CR) is a robust dietary intervention known to enhance cardiovascular health. AMP activated protein kinase (AMPK) has been suggested to mediate the cardioprotective effects of CR. However, this hypothesis remains to be tested by using definitive loss-of-function animal models. In the present study, we subjected AMPKα2 knockout (KO) mice and their wild type (WT) littermates to a CR regimen that reduces caloric intake by 20%–40% for 4 weeks. CR decreased body weight, heart weight and serum levels of insulin in both WT and KO mice to the same degree, indicating the effectiveness of the CR protocol. CR activated cardiac AMPK signaling in WT mice, but not in AMPKα2 KO mice. Correspondingly, AMPKα2 KO mice had markedly reduced cardiac function during CR as determined by echocardiography and hemodynamic measurements. The compromised cardiac function was associated with increased markers of oxidative stress, endoplasmic reticulum stress and myocyte apoptosis. Mechanistically, CR down-regulated the expression of ATP5g2, a subunit of mitochondrial ATP synthase, and reduced ATP content in AMPKα2 KO hearts, but not in WT hearts. In addition, CR accelerated cardiac autophagic flux in WT mice, but failed to do so in AMPKα2 KO mice. These results demonstrated that without AMPK, CR triggers adverse effects that can lead to cardiac dysfunction, suggesting that AMPK signaling pathway is indispensible for energy homeostasis and myocardial adaptation to CR, a dietary intervention that normally produces beneficial cardiac effects.
Highlights
Caloric restriction (CR) is a robust anti-aging intervention
The following antibodies were purchased from Cell Signaling (Danvers, MA): AMPKa, AMPKa1, AMPKa2, Phospho-AMPKa (Thr172), AMPKb1/2, Phospho- AMPKb1 (Ser108), Acetyl-CoA Carboxylase (ACC), Phospho-ACC (Ser79), Tuberin/Tuberous sclerosis protein 2 (TSC2), Phospho-TSC2 (Ser1387), microtubule-associated protein light chain 3 (LC3), C/EBP homologous protein (CHOP), 78 kD glucose-regulated protein (GRP78) or BIP, Protein disulfide isomerase (PDI), RNA activated protein kinase (PKR)-like endoplasmic reticulum kinase (PERK), Inositol-Requiring Enzyme 1 Alpha (IRE1a), Unc-51-like kinase 1 (ULK1), Phospho-ULK1 (Ser555), Beclin 1, Atg 5, Atg7, Atg12, Atg16L1, and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
Long-term CR in animals induces a host of changes at organ, cellular and molecular levels, among which are reduced body weight (BW) and serum levels of several hormones including insulin and insulin-like growth factor 1 (IGF-1) [3,30]
Summary
Caloric restriction (CR) is a robust anti-aging intervention. It refers to the practice that reduces calorie intake by 20–50% without causing malnutrition. The life extension effect of CR in long-lived primates such as rhesus monkeys remains controversial [5,6], casting some doubt on the hope that CR may be an effective approach to promote longevity in humans. Despite this uncertainty, ample evidence indicates that CR can produce dramatic cardiovascular benefits in humans [7,8,9,10]. CR is sufficient to reduce heart mass and attenuate ventricular chamber stiffness thereby improving diastolic cardiac function in humans [13,14,15]. The mechanisms of cardioprotection by CR remain speculative, making it hard to design mimetics for harnessing the full benefits of CR
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have